Charalampos Floudas, M.D.
National Cancer Institute (NCI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Charalampos Floudas, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:35 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07667400 · Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate CancerNational Cancer Institute (NCI) · recruiting · Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Paranasal Sinus Neoplasms · principal investigator
- Ph2NCT06176989 · Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base TumorsNational Cancer Institute (NCI) · recruiting · Metastatic Chondrosarcoma, Locally Advanced Chondrosarcoma, Metastatic Sinonasal Adenocarcinoma · principal investigator
- Ph2NCT06161545 · Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell CarcinomaNational Cancer Institute (NCI) · recruiting · Stage II Squamous Cell Carcinoma of the Head and Neck, Stage III Squamous Cell Carcinoma of the Head and Neck, Stage IV Squamous Cell Carcinoma of the Head and Neck · principal investigator
- Ph2NCT05996523 · Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal CancerNational Cancer Institute (NCI) · active not recruiting · Oropharyngeal Squamous Cell Carcinoma (SCC) · principal investigator
- Ph2NCT05012098 · Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).National Cancer Institute (NCI) · completed · Olfactory Neuroblastoma, Esthesioneuroblastoma, Neoplasm of the Nasal Cavity · principal investigator
- Ph2NCT04847466 · Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck CancerNational Cancer Institute (NCI) · completed · Gastroesophageal Junction (GEJ) Cancers, Advanced HNSCC · principal investigator
- N/ANCT04755205 · A Natural History Study of Children and Adults With Olfactory NeuroblastomaNational Cancer Institute (NCI) · recruiting · Olfactory Neuroblastoma, Esthesioneuroblastoma · principal investigator
- Ph1/Ph2NCT04432597 · HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated CancersNational Cancer Institute (NCI) · completed · HPV Positive Cancer, Vulvar, Vaginal, Penile, Rectal Cancer, Anal Cancer · principal investigator
- Ph1/Ph2NCT04287868 · Combination Immunotherapy in Subjects With Advanced HPV Associated MalignanciesNational Cancer Institute (NCI) · completed · Cervical Cancer, HPV Cancers, Anal Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in neuroblastoma.